Researchers locate geographic origins from DNA

One day soon, you may be able to pinpoint the geographic origins of your ancestors based on analysis of your DNA

05-Sep-2008 - A study published in Nature by an international team that included Cornell researchers describes the use of DNA to predict the geographic origins of individuals from a sample of Europeans, often within a few hundred kilometers of where they were born. "What we found is that within Europe, ...

Thermo Fisher Scientific Extends Reach in India with Addition of Leading Laboratory Chemicals Supplier

30-Jul-2007 - Thermo Fisher Scientific Inc. announced it has entered into an agreement to acquire Qualigens Fine Chemicals, a division of GlaxoSmithKline Pharmaceuticals Ltd. (GSK India) based in Mumbai. Qualigens is India's largest laboratory chemical manufacturer and supplier, serving customers in a variety ...

Out of REACH

New legislation threatens medicines

21-Nov-2006 - Europe's proposed new chemicals legislation, REACH, could disrupt the supply of important medicines. David Vosvenieks, REACH issue manager at AstraZeneca (AZ), told Chemistry & Industry that two companies supplying intermediates required for two AZ drugs - one of them an anticancer therapy - have ...

Structure of Human Cytochrome P450 2D6 solved by GlaxoSmithKline with the use of Fludigm Technology

21-Mar-2006 - The TOPAZ® system for protein crystallization was instrumental in helping GlaxoSmithKline (GSK) solve the structure of cytochrome P450 2D6, an enzyme important in the metabolism of a wide variety of drugs. TOPAZ crystallization chips were used to identify positive conditions for crystallization ...

GlaxoSmithKline Biologicals and Aeras Global TB Vaccine Foundation Partner To Develop New TB Vaccine

24-Oct-2005 - GlaxoSmithKline Biologicals (GSK Biologicals) and the Aeras Global TB Vaccine Foundation (Aeras) announced a new public-private partnership to develop GSK Biologicals' tuberculosis candidate vaccine Mtb72F/AS02A, which has shown promising results in preclinical studies. In addition, the vaccine ...